Skip to main content

Douglas M. VanOort

Equibles does not estimate personal net worth.

Get an email with a short summary when Neogenomics Inc publishes a filing, an earnings call transcript or a press release.

Get NEO alerts

About Douglas M. VanOort

Douglas M. VanOort is recorded as Chairman at Neogenomics Inc (NEO) since April 19, 2021. The proxy statement of Neogenomics Inc reports total compensation of $4,122,039 for Douglas M. VanOort in fiscal 2020, including a base salary of $669,039. Disclosed compensation is on record for 4 fiscal years. Neogenomics Inc is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at Neogenomics Inc includes Chris Smith (CEO and Board Member), Christopher Smith (CEO and Board Member), Tony Zook (CEO, Chairman and Board Member) and 7 others.

Affiliation history

Company network

Current role

Diagnostics & Research · Healthcare

Chairman

2021-04-19–present

Leadership on record at Neogenomics Inc

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2020 Neogenomics Inc (NEO) $669,039 $4,122,039
2019 Neogenomics Inc (NEO) $665,000 $3,648,732
2018 Neogenomics Inc (NEO) $641,923 $3,347,219
2017 Neogenomics Inc (NEO) $616,346 $3,483,508

Recent activity

No call appearances or filed executive changes recorded yet.